Vascular Anomaly
📧 Sign up to get email alerts when something new happens for Vascular Anomaly.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: 24VA022; VATCH Alpelisib for TIE2/PIK3CA Pathway VAs [Phase 2]
This is a Phase 2 clinical trial update for alpelisib (Piqray) targeting TIE2/PIK3CA pathway–driven vascular anomalies. The study is sponsor…
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: Topical Rapamycin/Sirolimus for Complicated Vascular Anomalies and Other Susceptible Lesions [Phase 1]
A Phase 1 clinical trial evaluating topical rapamycin (sirolimus) for complicated vascular anomalies has been terminated.